Second-Line Treatment for HR+, HER2- Metastatic Breast Cancer
In this Community Case Forum series, experts and participants discuss the evolving landscape of second-line treatment for patients with HR+, HER2- metastatic breast cancer.
CAR T-Cell Therapies for Multiple Myeloma
As part of its Community Case Forum series, key opinion leaders and participants discuss the use of CAR T-cell therapy for the treatment of patients with multiple myeloma.
Development of Immunotherapy for Advanced Endometrial Cancer
As part of its Community Case Forum series, key opinion leaders and participants discuss the development of immunotherapy for patients with advanced endometrial cancer.
Pembrolizumab Plus Chemo Improves Overall Survival in Resectable Gastric Cancer
Ibrutinib-Venetoclax Combo Elicits Durable Complete Responses in TP53+ MCL
Brentuximab Vedotin Triplet Provides Stronger Survival Signal vs R2 in R/R DLBCL
Durvalumab Plus Chemo Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer